20
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Preterm delivery: an overview

, &
Pages 687-704 | Published online: 07 Aug 2009

References

  • Norwitz ER, Robinson JN. A systematic approach to the management of preterm labor. Semin Perinatol 2001; 25: 223–35.
  • NHMRC, National Health and Medical Research Council. Clinical practice guidelines. Care around preterm birth. 1997. Available from: http://www.health.gov.au/nhmrc/publications/pdf/cp51.pdf.
  • Byrne B, Morrison J. Preterm birth. Clin Evid 2002; 1310–24.
  • The European Atosiban Study Group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001; 80: 413–22.
  • Challis JR. Understanding pre-term birth. Clin Invest Med 2001; 24: 60–7.
  • Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020–37.
  • Challis JRG. Mechanism of parturition and preterm labor. Obstet Gynecol Surv 2000; 55: 650–60.
  • Junqueira LC, Carneiro J, Kelley RO. Muscle tissue. In: Junqueira LC, Carneiro J, Kelley RO, eds. Basic histology. London: Appelton & Lange, 1989: 194–213.
  • Bernal AL. Prematurity. Timing of parturition. Lancet 2001; 358: S51.
  • Garfield RE, Ali M, Yallampalli C, Izumi H. Role of gap junctions and nitric oxide in control of myometrial contractility. Semin Perinatol 1995; 19: 41–51.
  • Buxton IL, Crow W, Mathew SO. Regulation of uterine contraction: mechanisms in preterm labor. AACN Clin Issues 2000; 11: 271–82.
  • Ivanisevic M, Djelmis J, Bukovic D. Review on prostaglandin and oxytocin activity in preterm labor. Coll Antropol 2001; 25: 687–94.
  • Challis JR, Smith SK. Fetal endocrine signals and preterm labor. Biol Neonate 2001; 79: 163–7.
  • Grammatopoulos DK, Hillhouse EW. Role of corticotropin-releasing hormone in onset of labour. Lancet 1999; 354: 1546–9.
  • Huszar GB, Walsh MP. Relationship between myometrial and cervical functions in pregnancy and labor. Semin Perinatol 1991; 15: 97–117.
  • Vermeulen GM. Spontaneous preterm birth: prevention, management and outcome. Eur J Obstet Gynecol Reprod Biol 2000; 93: 1–3.
  • Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998; 339: 313–20.
  • Fødsler i Norge 1999–2000. Annual report. Bergen: Medical Birth Registry of Norway and University of Bergen, 2002.
  • The National Board of Health and Welfare, Sweden. 2003: http://www.sos.se/epc/fs/index.htm.
  • Welfare and Health Care Statistics, Finland. 2003: http://www.stakes.info/files/pdf/tiedonantajapalautteet/2002/Tp15_02.pdf.
  • The National Board of Health and Welfare. 2000: http://192.137.163.40/EPCFS/.
  • Geirsson Reynir T. Personal communication, 2003.
  • Bakketeig LS, Bjerkedal T, Hoffman HJ. Small-for-gestational age births in successive pregnancy outcomes: results from a longitudinal study of births in Norway. Early Hum Dev 1986; 14: 187–200.
  • Steer P, Flint C. ABC of labour care: preterm labour and premature rupture of membranes. Br Med J 1999; 318: 1059–62.
  • Bennett AD. Perinatal substance abuse and the drug exposed neonate. Adv Nurs Pract 1999; 7: 32–6.
  • Lumley J. The epidemiology of preterm birth. Bailliere’s Clin Obstet Gynaecol 1993; 7: 477–98.
  • Newman RB, Goldenberg RL, Moawad AH, Iams JD, Meis PJ, Das A et al. Occupational fatigue and preterm premature rupture of membranes. National Institute of Child Health and Human Development Maternal-Fetal Medicine, Units Network. Am J Obstet Gynecol 2001; 184: 438–46.
  • Scholl TO, Hediger ML, Fischer RL, Shearer JW. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr 1992; 55: 985–8.
  • Weerakul W, Chittacharoen A, Suthutvoravut S. Nifedipine versus terbutaline in management of preterm labor. Int J Gynaecol Obstet 2002; 76: 311–13.
  • Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP. Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population. Am J Obstet Gynecol 1990; 162: 213–18.
  • Wisborg K, Henriksen TB, Hedegaard M, Secher NJ. Smoking during pregnancy and preterm birth. Br J Obstet Gynaecol 1996; 103: 800–5.
  • Clausson B, Granath F, Ekbom A, Lundgren S, Nordmark A, Signorello LB et al. Effect of caffeine exposure during pregnancy on birth weight and gestational age. Am J Epidemiol 2002; 155: 429–36.
  • Siega-Riz AM, Adair LS, Hobel CJ. Institute of Medicine maternal weight gain recommendations and pregnancy outcome in a predominantly Hispanic population. Obstet Gynecol 1994; 84: 565–73.
  • Wildschut HJJ. Maternal weight and weight gain. In: James DK, Steer PJ, Weiner CP, Gonik B, eds. High risk pregnancy. Management options. London: Saunders, 1994: 67–74.
  • Furneaux EC, Langley-Evans AJ, Langley-Evans SC. Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstet Gynecol Surv 2001; 56: 775–82.
  • Brinch M, Isager T, Tolstrup K. Anorexia nervosa and motherhood: reproduction pattern and mothering behavior of 50 women. Acta Psychiatr Scand 1988; 77: 611–17.
  • Fahy TA, Morrison JJ. The clinical significance of eating disorders in obstetrics. Br J Obstet Gynaecol 1993; 100: 708–10.
  • Siega-Riz AM, Herrmann TS, Savitz DA, Thorp JM. Frequency of eating during pregnancy and its effect on preterm delivery. Am J Epidemiol 2001; 153: 647–52.
  • Lamont RF. The prevention of preterm birth with the use of antibiotics. Eur J Pediatr 1999; 158: S2–4.
  • Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002; 8: 3–13.
  • Ovalle A, Levancini M. Urinary tract infections in pregnancy. Curr Opin Urol 2001; 11: 55–9.
  • Kirschbaum T. Antibiotics in the treatment of preterm labor. Am J Obstet Gynecol 1993; 168: 1239–46.
  • Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500–7.
  • El Bastawissi AY, Williams MA, Riley DE, Hitti J, Krieger JN. Amniotic fluid interleukin-6 and preterm delivery: a review. Obstet Gynecol 2000; 95: 1056–64.
  • Mercer BM. Management of preterm premature rupture of the membranes. Clin Obstet Gynecol 1998; 41: 870–82.
  • Ustun C, Kocak I, Baris S, Uzel A, Saltik F. Subclinical chorioamnionitis as an etiologic factor in preterm deliveries. Int J Gynaecol Obstet 2001; 72: 109–15.
  • Carroll S. The role of prophylactic antibiotic therapy for preterm labour and preterm prelabour rupture of the membranes. Ir Med J 2001; 94: 196–7.
  • Gibbs RS. The relationship between infections and adverse pregnancy outcomes: an overview. Ann Periodontol 2001; 6: 153–63.
  • Andrews WW, Goldenberg RL, Mercer B, Iams J, Meis P, Moawad A et al. The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183: 662–8.
  • Adinkra P, Lamont RF. Adverse obstetric sequelae of bacterial vaginosis. Hosp Med 2000; 61: 475–7.
  • Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract 1999; 48: 885–92.
  • Gjerdingen D, Fontaine P, Bixby M, Santilli J, Welsh J. The impact of regular vaginal pH screening on the diagnosis of bacterial vaginosis in pregnancy. J Fam Pract 2000; 49: 39–43.
  • McGregor JA, French JI. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000; 55: S1–19.
  • Pastore LM, Hartmann KE, Thorp JM Jr, Royce RA, Jackson TP, Savitz DA. Bacterial vaginosis and cervical dilation and effacement at 24–29 weeks’ gestation. Am J Perinatol 2000; 17: 83–8.
  • Jacobsson B, Pernevi P, Chidekel L, Jorgen PlatzChristensen J. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet Gynecol Scand 2002; 81: 1006–10.
  • Hill GB. Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol 1998; 3: 222–32.
  • Offenbacher S, Lieff S, Boggess KA, Murtha AP, Madianos PN, Champagne CM et al. Maternal periodontitis and prematurity. Part I. Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001; 6: 164–74.
  • Olsen SF, Secher NJ. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. Br Med J 2002; 324: 447.
  • Bendich A. Micronutrients in women’s health and immune function. Nutrition 2001; 17: 858–67.
  • Ramakrishnan U, Manjrekar R, Rivera J, Gonzales Cossio T, Martorell R. Micronutrients and pregnancy outcome: a review of the literature. Nutr Res 1999; 19: 103–59.
  • Leung TY, Chan LW, Tam WH, Leung TN, Lau TK. Risk and prediction of preterm delivery in pregnancies complicated by antepartum hemorrhage of unknown origin before 34 weeks. Gynecol Obstet Invest 2001; 52: 227–31.
  • Rosen T, Kuczynski E, O’Neill LM, Funai EF, Lockwood CJ. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001; 10: 297–300.
  • Heffner LJ, Sherman CB, Speizer FE, Weiss ST. Clinical and environmental predictors of preterm labor. Obstet Gynecol 1993; 81: 750–7.
  • Boer K, Smit BJ, van Huis AM, Hogerzeil HV. Substance use in pregnancy: do we care? Acta Paediatr Suppl 1994; 404: 65–71.
  • Ellwood DA, Sutherland P, Kent C, O’Connor M. Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust N Z J Obstet Gynaecol 1987; 27: 92–8.
  • Fulroth R, Phillips B, Durand DJ. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am J Dis Child 1989; 143: 905–10.
  • Cooney MJ, Benson CB, Doubilet PM. Outcome of pregnancies in women with uterine duplication anomalies. J Clin Ultrasound 1998; 26: 3–6.
  • Kirkinen P, Jouppila P. Polyhydramnion. A clinical study. Ann Chir Gynaecol 1978; 67: 117–22.
  • Lazebnik N, Many A. The severity of polyhydramnios, estimated fetal weight and preterm delivery are independent risk factors for the presence of congenital malformations. Gynecol Obstet Invest 1999; 48: 28–32.
  • Heinonen PK. Unicornuate uterus and rudimentary horn. Fertil Steril 1997; 68: 224–30.
  • Heydanus R, Raats MA, Tibboel D, Los FJ, Wladimiroff JW. Prenatal diagnosis of fetal abdominal wall defects: a retrospective analysis of 44 cases. Prenat Diagn 1996; 16: 411–17.
  • Linhart Y, Bashiri A, Maymon E, Shoham-Vardi I, Furman B, Vardi H et al. Congenital anomalies are an independent risk factor for neonatal morbidity and perinatal mortality in preterm birth. Eur J Obstet Gynecol Reprod Biol 2000; 90: 43–9.
  • Lobel M, DeVincent CJ, Kaminer A, Meyer BA. The impact of prenatal maternal stress and optimistic disposition on birth outcomes in medically high-risk women. Health Psychol 2000; 19: 544–53.
  • Dayan J, Creveuil C, Herlicoviez M, Herbel C, Baranger E, Savoye C et al. Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol 2002; 155: 293–301.
  • Wadhwa PD, Culhane JF, Rauh V, Barve SS, Hogan V, Sandman CA et al. Stress, infection and preterm birth: a biobehavioural perspective. Paediatr Perinat Epidemiol 2001; 15: 17–29.
  • Spencer N, Logan S. Social influences on birth weight. J Epidemiol Community Health 2002; 56: 326–7.
  • Spencer N, Bambang S, Logan S, Gill L. Socioeconomic status and birth weight: comparison of an area-based measure with the Registrar General’s social class. J Epidemiol Community Health 1999; 53: 495–8.
  • Kramer MS, Goulet L, Lydon J, Seguin L, McNamara H, Dassa C et al. Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol 2001; 15: 104–23.
  • Fernandez FM, Krueger PM. Domestic violence: effect on pregnancy outcome. J Am Osteopath Assoc 1999; 99: 254–6.
  • Connolly AM, Katz VL, Bash KL, McMahon MJ, Hansen WF. Trauma and pregnancy. Am J Perinatol 1997; 14: 331–6.
  • Smith GC, Pell JP. Teenage pregnancy and risk of adverse perinatal outcomes associated with first and second births: population based retrospective cohort study. Br Med J 2001; 323: 476.
  • Higby K, Xenakis EM, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993; 168: 1247–56.
  • Bakketeig LS, Hoffman HJ, Harley EE. The tendency to repeat gestational age and birth weight in successive births. Am J Obstet Gynecol 1979; 135: 1086–103.
  • Carr-Hill RA, Hall MH. The repetition of spontaneous preterm labour. Br J Obstet Gynaecol 1985; 92: 921–8.
  • Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993; 168: 585–91.
  • Germain AM, Carvajal J, Sanchez M, Valenzuela GJ, Tsunekawa H, Chuaqui B. Preterm labor: placental pathology and clinical correlation. Obstet Gynecol 1999; 94: 284–9.
  • Jones JM, Sweetnam P, Hibbard BM. The outcome of pregnancy after cone biopsy of the cervix: a case-control study. Br J Obstet Gynaecol 1979; 86: 913–16.
  • Raio L, Ghezzi F, Di Naro E, Gomez R, Luscher KP. Duration of pregnancy after carbon dioxide laser conization of the cervix: influence of cone height. Obstet Gynecol 1997; 90: 978–82.
  • van Rooijen M, Persson E. Pregnancy outcome after laser vaporization of the cervix. Acta Obstet Gynecol Scand 1999; 78: 346–8.
  • Weber T, Obel EB. Pregnancy complications following conization of the uterine cervix (II). Acta Obstet Gynecol Scand 1979; 58: 347–51.
  • Hagen B, Skjeldestad FE. The outcome of pregnancy after CO2 laser conisation of the cervix. Br J Obstet Gynaecol 1993; 100: 717–20.
  • Iversen OE, Tande T, Sandvei R. Outcome of pregnancy after laser conization for cervical epithelial neoplasia. (CIN). Fourth Biannual meeting of the International Gynecological Cancer Society. Stockholm, Aug-Sep 1993; Abstract: 24.
  • Locksmith G, Duff P. Infection, antibiotics, and preterm delivery. Semin Perinatol 2001; 25: 295–309.
  • Jun JK, Yoon BH, Romero R, Kim M, Moon JB et al. Interleukin 6 determinations in cervical fluid have diagnostic and prognostic value in preterm premature rupture of membranes. Am J Obstet Gynecol 2000; 183: 868–73.
  • Goepfert AR, Goldenberg RL, Andrews WW, Hauth JC, Mercer B, Iams J et al. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2001; 184: 483–8.
  • Goffinet F, Maillard F, Fulla Y, Cabrol D. Biochemical markers (without markers of infection) of the risk of preterm delivery. Implications for clinical practice. Eur J Obstet Gynecol Reprod Biol 2001; 94: 59–68.
  • Leitich H, Egarter C, Kaider A, Hohlagschwandtner M, Berghammer P, Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol 1999; 180: 1169–76.
  • Yoon BH, Romero R, Moon JB, Oh SY, Han SY, Kim JC et al. The frequency and clinical significance of intra-amniotic inflammation in patients with a positive cervical fetal fibronectin. Am J Obstet Gynecol 2001; 185: 1137–42.
  • McGrath S, McLean M, Smith D, Bisits A, Giles W, Smith R. Maternal plasma corticotropin-releasing hormone trajectories vary depending on the cause of preterm delivery. Am J Obstet Gynecol 2002; 186: 257–60.
  • Goldenberg RL, Andrews WW, Guerrant RL, Newman M, Mercer B, Iams J et al. The preterm prediction study: cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth. National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Am J Obstet Gynecol 2000; 182: 631–5.
  • Marvin KW, Keelan JA, Sato TA, Coleman MA, McCowan LM, Mitchell MD. Expression of intercellular adhesion molecule-1 (ICAM-1) in choriodecidua with labour and delivery at term and preterm. Reprod Fertil Dev 1999; 11: 255–62.
  • Bernstein PS, Stern R, Lin N, Furgiuele J, Karmen A, Comerford-Freda M et al. Beta-human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery. Am J Obstet Gynecol 1998; 179: 870–3.
  • Naylor CS, Gregory K, Hobel C. Premature rupture of the membranes: an evidence-based approach to clinical care. Am J Perinatol 2001; 18: 397–413.
  • American College of Obstetricians and Gynecologists. Assessment of risk factors for preterm birth. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2001; 98: 709–16.
  • Gomez R, Galasso M, Romero R, Mazor M, Sorokin Y, Goncalves L et al. Ultrasonographic examination of the uterine cervix is better than cervical digital examination as a predictor of the likelihood of premature delivery in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1994; 171: 956–64.
  • Guzman ER, Ananth CV. Cervical length and spontaneous prematurity: laying the foundation for future interventional randomized trials for the short cervix. Ultrasound Obstet Gynecol 2001; 18: 195–9.
  • Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Network. N Engl J Med 1996; 334: 567–72.
  • Cook CM, Ellwood DA. The cervix as a predictor of preterm delivery in ‘at-risk’ women. Ultrasound Obstet Gynecol 2000; 15: 109–13.
  • Heath VC, Southall TR, Souka AP, Elisseou A, Nicolaides KH. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 1998; 12: 312–17.
  • Leitich H, Brunbauer M, Kaider A, Egarter C, Husslein P. Cervical length and dilatation of the internal cervical os detected by vaginal ultrasonography as markers for preterm delivery: a systematic review. Am J Obstet Gynecol 1999; 181: 1465–72.
  • Dowd J, Permezel M, Garland S, de Crespigny L. Is there an interaction between cervical length and cervical microbiology in the pathogenesis of preterm labour? Aust N Z J Obstet Gynaecol 2001; 41: 177–81.
  • Iams JD. Cervical ultrasonography. Ultrasound Obstet Gynecol 1997; 10: 156–60.
  • Guzman ER, Walters C, Ananth CV, O’Reilly-Green C, Benito CW, Palmero A et al. A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton gestations. Ultrasound Obstet Gynecol 2001; 18: 204–10.
  • MacDonald R, Smith P, Vyas S. Cervical incompetence: the use of transvaginal sonography to provide an objective diagnosis. Ultrasound Obstet Gynecol 2001; 18: 211–16.
  • Rozenberg P, Gillet A, Ville Y. Transvaginal sonographic examination of the cervix in asymptomatic pregnant women: review of the literature. Ultrasound Obstet Gynecol 2002; 19: 302–11.
  • MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993; 100: 516–23.
  • Rust OA, Atlas RO, Reed J, van Gaalen J, Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol 2001; 185: 1098–105.
  • Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001; 185: 1106–12.
  • To MS, Palaniappan V, Skentou C, Gibb D, Nicolaides KH. Elective cerclage vs. ultrasound indicated cerclage in high-risk pregnancies. Ultrasound Obstet Gynecol 2002; 19: 475–7.
  • Heath VC, Souka AP, Erasmus I, Gibb DM, Nicolaides KH. Cervical length at 23 weeks of gestation. the value of Shirodkar suture for the short cervix. Ultrasound Obstet Gynecol 1998; 12: 318–22.
  • Chasen ST, Silverman NS. Mid-trimester emergent cerclage: a ten year single institution review. J Perinatol 1998; 18: 338–42.
  • Hordnes K, Askvik K, Dalaker K. Emergency McDonald cerclage with application of stay sutures. Eur J Obstet Gynecol Reprod Biol 1996; 64: 43–9.
  • Locatelli A, Vergani P, Bellini P, Strobelt N, Arreghini A, Ghidini A. Amnioreduction in emergency cerclage with prolapsed membranes: comparison of two methods for reducing the membranes. Am J Perinatol 1999; 16: 73–7.
  • MacDougall J, Siddle N. Emergency cervical cerclage. Br J Obstet Gynaecol 1991; 98: 1234–8.
  • Wong GP, Farquharson DF, Dansereau J. Emergency cervical cerclage. a retrospective review of 51 cases. Am J Perinatol 1993; 10: 341–7.
  • Wu MY, Yang YS, Huang SC, Lee TY, Ho HN. Emergent and elective cervical cerclage for cervical incompetence. Int J Gynaecol Obstet 1996; 54: 23–9.
  • Davis G, Berghella V, Talucci M, Wapner RJ. Patients with a prior failed transvaginal cerclage: a comparison of obstetric outcomes with either transabdominal or transvaginal cerclage. Am J Obstet Gynecol 2000; 183: 836–9.
  • The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327: 308–12.
  • King J, Flenady V. Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev 2000: CD000246.
  • Lam F, Elliott J, Jones JS, Katz M, Knuppel RA, Morrison J et al. Clinical issues surrounding the use of terbutaline sulfate for preterm labor. Obstet Gynecol Surv 1998; 53: S85–95.
  • Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial. Am J Obstet Gynecol 1998; 179: 874–8.
  • Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Reply. Am J Obstet Gynecol 1999; 180: 1593–4.
  • Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329: 1602–7.
  • Suarez RD, Grobman WA, Parilla BV. Indomethacin tocolysis and intraventricular hemorrhage. Obstet Gynecol 2001; 97: 921–5.
  • Goldenberg RL, Cliver SP. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol 1992; 79: 1054–5.
  • Higby K, Suiter CR. A risk–benefit assessment of therapies for premature labour. Drug Safety 1999; 21: 35–56.
  • Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R. Adverse and beneficial effects of tocolytic therapy. Semin Perinatol 2001; 25: 316–40.
  • Humphrey RG, Bartfield MC, Carlan SJ, O’Brien WF, O’Leary TD, Triana T. Sulindac to prevent recurrent preterm labor: a randomized controlled trial. Obstet Gynecol 2001; 98: 555–62.
  • Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999; 94: 869–77.
  • Keirse MJ. Magnesium sulphate in preterm labour. Review no. 06192. In: Enkin MW, Keirse MJ, Renfew MJ, eds. Pregnancy, and childbirth module, Cochrane pregnancy and childbirth database. Oxford: Update Software, 1995.
  • Macones GA, Sehdev HM, Berlin M, Morgan MA, Berlin JA. Evidence for magnesium sulfate as a tocolytic agent. Obstet Gynecol Surv 1997; 52: 652–8.
  • Economy KE, Abuhamad AZ. Calcium channel blockers as tocolytics. Semin Perinatol 2001; 25: 264–71.
  • Kupferminc M, Lessing JB, Yaron Y, Peyser MR. Nifedipine versus ritodrine for suppression of preterm labour. Br J Obstet Gynaecol 1993; 100: 1090–4.
  • Papatsonis DN, van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997; 90: 230–4.
  • Caughey AB, Parer JT. Tocolysis with beta-adrenergic receptor agonists. Semin Perinatol 2001; 25: 248–55.
  • King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour (Cochrane Review). Cochrane Database Syst Rev 2002: CD002255.
  • Oei SG, Mol BW, de Kleine MJ, Brolmann HA. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis. Acta Obstet Gynecol Scand 1999; 78: 783–8.
  • Tsatsaris V, Carbonne B, Papatsonis D, Goffinet F. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis. Acta Obstet Gynecol Scand 2000; 79: 618–19.
  • Carr DB, Clark AL, Kernek K, Spinnato JA. Maintenance oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol 1999; 181: 822–7.
  • Goodwin TM, Zograbyan A. Oxytocin receptor antagonists. Update. Clin Perinatol 1998; 25: 859–71.
  • Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000; 182: 1184–90.
  • Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000; 182: 1173–83.
  • The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol 2001; 108: 133–42.
  • Terzidou V, Bennett PR. Preterm labour. Curr Opin Obstet Gynecol 2002; 14: 105–13.
  • Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002; 360: 1489–97.
  • Rust OA. Preterm delivery: risks versus benefits of intervention. Curr Womens Health Rep 2002; 2: 59–64.
  • Cabrol D, MacLennan AH for the French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a doubleblind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001; 98: 177–85.
  • Besinger RE, Niebyl JR, Keyes WG, Johnson TR. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol 1991; 164: 981–6.
  • Kramer WB, Saade GR, Belfort M, Dorman K, Mayes M, Moise KJ Jr. A randomized double-blind study comparing the fetal effects of sulindac to terbutaline during the management of preterm labor. Am J Obstet Gynecol 1999; 180: 396–401.
  • Papatsonis DN, van Geijn HP, Dekker GA. Management of preterm labour. Nifedipine in management of preterm labour is safe. Br Med J 1999; 319: 257.
  • Kelly MK, Schneider EP, Petrikovsky BM, Lesser ML. Effect of antenatal steroid administration on the fetal biophysical profile. J Clin Ultrasound 2000; 28: 224–6.
  • Vermillion ST, Soper DE, Bland ML, Newman RB. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes. Am J Obstet Gynecol 2000; 183: 925–9.
  • Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995; 173: 322–35.
  • McNamara MF, Bottoms SF. The incidence of respiratory distress syndrome does not increase when preterm delivery occurs greater than 7 days after steroid administration. Aust N Z J Obstet Gynaecol 1998; 38: 8–10.
  • Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000; CD000065.
  • Dirnberger DR, Yoder BA, Gordon MC. Single versus repeated-course antenatal corticosteroids: outcomes in singleton and multiple-gestation pregnancies. Am J Perinatol 2001; 18: 267.
  • Smith LM, Qureshi N, Chao CR. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks’ gestation. J Matern Fetal Med 2000; 9: 131–5.
  • Chapman SJ, Hauth JC, Bottoms SF, Iams JD, Sibai B, Thom E et al. Benefits of maternal corticosteroid therapy in infants weighing ≤1000 grams at birth after preterm rupture of the amnion. Am J Obstet Gynecol 1999; 180: 677–82.
  • Lawson EE. Antenatal corticosteroids – too much of a good thing? J Am Med Assoc 2001; 286: 1628–30.
  • Goldenberg RL, Wright LL. Repeated courses of antenatal corticosteroids. Obstet Gynecol 2001; 97: 316–17.
  • Mastrobattista JM. Therapeutic agents in preterm labor: steroids. Clin Obstet Gynecol 2000; 43: 802–8.
  • Vermillion ST, Soper DE, Newman RB. Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. Am J Obstet Gynecol 2000; 183: 810–14.
  • Whitelaw A, Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 2000; 83: F154–7.
  • Kay HH, Bird IM, Coe CL, Dudley DJ. Antenatal steroid treatment and adverse fetal effects: what is the evidence? J Soc Gynecol Invest 2000; 7: 269–78.
  • McEvoy C, Bowling S, Williamson K, Collins J, Tolaymat L, Maher J. Timing of antenatal corticosteroids and neonatal pulmonary mechanics. Am J Obstet Gynecol 2000; 183: 895–9.
  • Myers ER, Alvarez JG, Richardson DK, Ludmir J. Cost-effectiveness of fetal lung maturity testing in preterm labor. Obstet Gynecol 1997; 90: 824–9.
  • Henderson CE, Goldman B, Divon MY. Ritodrine therapy in the presence of chronic abruptio placentae. Obstet Gynecol 1992; 80: 510–12.
  • Besinger RE, Moniak CW, Paskiewicz LS, Fisher SG, Tomich PG. The effect of tocolytic use in the management of symptomatic placenta previa. Am J Obstet Gynecol 1995; 172: 1770–5.
  • Autret-Leca E, Jonville-Bera AP. Vitamin K in neonates: how to administer, when and to whom. Paediatr Drugs 2001; 3: 1–8.
  • Aydinli N, Citak A, Caliskan M, Karabocuoglu M, Baysal S, Ozmen M. Vitamin K deficiency — late onset intracranial haemorrhage. Eur J Paediatr Neurol 1998; 2: 199–203.
  • Suzuki S, Iwata G, Sutor AH. Vitamin K deficiency during the perinatal and infantile period. Semin Thromb Hemost 2001; 27: 93–8.
  • Crowther CA, Henderson-Smart DJ. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database Syst Rev 2001: CD000229.
  • Mamelle N, Segueilla M, Munoz F, Berland M. Prevention of preterm birth in patients with symptoms of preterm labor – the benefits of psychologic support. Am J Obstet Gynecol 1997; 177: 947–52.
  • Maxwell CV, Amankwah KS. Alternative approaches to preterm labor. Semin Perinatol 2001; 25: 310–15.
  • Kovacevich GJ, Gaich SA, Lavin JP, Hopkins MP, Crane SS, Stewart J et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol 2000; 182: 1089–92.
  • Haram K, Thordarson H, Hervig T. Calcium homeostasis in pregnancy and lactation. Acta Obstet Gynecol Scand 1993; 72: 509–13.
  • Crowther CA, Hiller JE, Pridmore B, Bryce R, Duggan P, Hague WM et al. Calcium supplementation in nulliparous women for the prevention of pregnancy induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. FRACOG and the ACT Study Group. Aust N Z J Obstet Gynaecol 1999; 39: 12–18.
  • Brown HL, Britton KA, Brizendine EJ, Hiett AK, Ingram D, Turnquest MA et al. A randomized comparison of home uterine activity monitoring in the outpatient management of women treated for preterm labor. Am J Obstet Gynecol 1999; 180: 798–805.
  • Goulet C, Gevry H, Gauthier RJ, Lepage L, Fraser W, Aita M. A controlled clinical trial of home care management versus hospital care management for preterm labour. Int J Nurs Stud 2001; 38: 259–69.
  • Sciscione AC, Stamilio DM, Manley JS, Shlossman PA, Gorman RT, Colmorgen GH. Tocolysis of preterm contractions does not improve preterm delivery rate or perinatal outcomes. Am J Perinatol 1998; 15: 177–81.
  • Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet 2001; 357: 989–94.
  • Lamont RF, Taylor-Robinson D, Hay PE. Antibiotics for adverse outcomes of pregnancy. Lancet 2001; 358: 1728–9.
  • Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000; 342: 534–40.
  • French JI, McGregor JA, Draper D, Parker R, McFee J. Gestational bleeding, bacterial vaginosis, and common reproductive tract infections. risk for preterm birth and benefit of treatment. Obstet Gynecol 1999; 93: 715–24.
  • Kurkinen-Raty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J et al. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. Br J Obstet Gynaecol 2000; 107: 1427–32.
  • McDonald HM, O’Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997; 104: 1391–7.
  • Svare J, Langhoff-Roos J, Andersen LF, Kryger Baggesen N, Borch-Christensen H, Borch-Christensen H et al. Ampicillin-metronidazole treatment in idiopathic preterm labour: a randomised controlled multicentre trial. Br J Obstet Gynaecol 1997; 104: 892–7.
  • Villar J, Gulmezoglu AM, de Onis M. Nutritional and antimicrobial interventions to prevent preterm birth: an overview of randomized controlled trials. Obstet Gynecol Surv 1998; 53: 575–85.
  • Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001; 97: 643–8.
  • Brocklehurst P, Hannah M, McDonald H. Interventions for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2000: CD000262.
  • Chandran R. Cochrane for clinicians: putting evidence into practice. Screening for and treating asymptomatic bacterial vaginosis in pregnancy. Am Fam Physician 2002; 66: 780–2.
  • Koumans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women. a synthesis of data. Clin Infect Dis 2002; 35: S152–72.
  • Ananth CV, Guise JM, Thorp JM Jr. Utility of antibiotic therapy in preterm premature rupture of membranes: a meta-analysis. Obstet Gynecol Surv 1996; 51: 324–8.
  • Egarter C, Leitich H, Karas H, Wieser F, Husslein P, Kaider A et al. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: a metaanalysis. Am J Obstet Gynecol 1996; 174: 589–97.
  • Tsatsaris V, Carbonne B, Cabrol D. Place of amniocentesis in the assessment of preterm labour. Eur J Obstet Gynecol Reprod Biol 2000; 93: 19–25.
  • Garite TJ. Management of premature rupture of membranes. Clin Perinatol 2001; 28: 837–47.
  • Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2000: CD000490.
  • Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebocontrolled double-blind trial. Br J Obstet Gynaecol 1999; 106: 652–7.
  • Scholl TO, Hediger ML, Schall JI, Khoo CS, Fischer RL. Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr 1996; 63: 520–5.
  • Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000; 71: 1295S–303S.
  • Blumenfeld Z, Brenner B. Thrombophilia-associated pregnancy wastage. Fertil Steril 1999; 72: 765–74.
  • Giles PFG, Harcourt AG, Whtteside MG. The effect of prescribing folic acid during pregnancy on birth weight and duration of pregnancy. A double-blind trial. Med J Aust 1971; 2: 17–21.
  • Rolschau J, Kristoffersen K, Ulrich M, Grinsted P, Schaumburg E, Foged N. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. Eur J Obstet Gynecol Reprod Biol 1999; 87: 105–10.
  • Bolisetty S, Naidoo D, Lui K, Koh TH, Watson D, Whitehall J. Antenatal supplementation of antioxidant vitamins to reduce the oxidative stress at delivery – a pilot study. Early Hum Dev 2002; 67: 47–53.
  • Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. Br J Obstet Gynaecol 2000; 107: 382–95.
  • Huel G, Campagna D, Girard F, Moreau T, Blot P. Does selenium reduce the risk of threatened preterm delivery associated with placental cytochrome P450-1A1 activity? Environ Res 2000; 84: 228–33.
  • Allen LH. Biological mechanisms that might underlie iron’s effects on fetal growth and preterm birth. J Nutr 2001; 131: 581S–9S.
  • deOnis M, Villar J, Gulmezoglu M. Nutritional interventions to prevent intrauterine growth retardation: evidence from randomized trials. Eur J Clin Nutr 1998; 53: S83–S93.
  • Finnstrom O, Olausson PO, Sedin G, Serenius F, Svenningsen N, Thiringer K et al. The Swedish national prospective study on extremely low birth weight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatr 1997; 86: 503–11.
  • Lewis R, Mercer BM, Salama M, Walsh MA, Sibai BM. Oral terbutaline after parenteral tocolysis: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1996; 175: 834–7.
  • Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996; 175: 838–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.